Alzheimer's disease detection in PSG signals

Lorena Gallego-Viñarás, Juan Miguel Mira-Tomas, Anna Michela-Gaeta, Gerard Pinol-Ripoll, Ferrán Barbé, Pablo M. Olmos, Arrate Muñoz-BarrutiaarXiv 2024 · DOI · arXiv

Introduction

Early diagnosis of Alzheimer’s Disease (AD) remains a critical challenge in geriatric medicine. Conventional diagnostic methods often rely on clinical symptoms that manifest only after significant neurodegeneration has occurred. Recent research indicates that sleep disruptions, detectable via polysomnography (PSG), may precede cognitive decline, offering a window for earlier intervention. However, the application of Deep Learning (DL) to PSG data is hindered by the scarcity of expert-labeled clinical data from AD patients. This study investigates a semi-supervised learning framework to bridge this gap, leveraging the SMATE model to achieve high diagnostic accuracy even with limited labeled data.

Methodology

The researchers evaluated four modeling approaches to classify EEG signals as "Healthy" or "AD":

  1. SMATE (Semi-Supervised Spatio-Temporal Representation Learning): A framework utilizing an autoencoder to map signals into an embedding space, followed by a three-step regularization process to cluster AD and healthy patterns using both labeled and unlabeled data.
  2. TapNet: A semi-supervised attentional prototypical network serving as a secondary benchmark.
  3. XCM: A supervised model employing 1D and 2D convolutions to extract temporal and spatial features simultaneously.
  4. Hidden Markov Models (HMM): An unsupervised statistical baseline.

A central technical contribution is the integration of spatio-temporal analysis. By examining both the timing and the scalp location of EEG signals, the models capture complex inter-regional brain dynamics often disrupted in AD.

The proposed pipeline from PSG studies through preprocessing of specific sleep stages to deep learning-based AD prediction.

Datasets and Preprocessing

To ensure robust performance, the study combined four distinct databases:

  • AD Patient Database: Clinical data from 58 individuals with mild-to-moderate AD.
  • Healthy Controls: Data aggregated from ISRUC-SLEEP (10 subjects), Dream Open Dataset-Healthy (25 subjects), and the Sleep Disorders Research Center (11 subjects).

Data harmonization involved standardizing sleep stages (N1, N2, N3, REM) and resampling all EEG signals to 128 Hz to ensure consistency across disparate sources.

Key Insights

  • Optimal Sleep Stage: The N1 sleep stage (transition from wakefulness to sleep) consistently yielded the most stable and accurate classification results.
  • Robustness to Label Scarcity: The SMATE model maintained high performance even when trained with only 10% of available labels, significantly outperforming TapNet in data-constrained scenarios.
  • Criticality of Spatial Features: Ablation studies confirmed that spatial modeling is essential. Removing the ability to analyze inter-channel relationships led to a sharp decline in accuracy, highlighting the importance of regional brain communication patterns in AD detection.
  • Age-Related Confounding: The authors implemented specific tests to distinguish between normal age-related EEG changes and AD-specific signatures, ensuring the models were not simply identifying the age of the subjects.

Results Evaluation

The supervised XCM model achieved the highest overall accuracy, ranging between 92% and 94% across all sleep stages. The SMATE model reached 90% accuracy in its supervised configuration and demonstrated remarkable stability in semi-supervised settings, making it highly suitable for clinical environments where labeled data is rare.

Evaluation of results showing clear separation of AD and Healthy subjects in the embedding space (t-SNE) and high ROC/AUC performance across sleep stages.

Visual validation via t-SNE embeddings confirmed that the SMATE model successfully forced AD and healthy samples into distinct, separable clusters, proving the model's ability to learn meaningful physiological signatures of the disease.

Conclusion and Future Work

This research demonstrates the potential of semi-supervised Deep Learning to transform routine sleep studies into early-warning systems for Alzheimer’s Disease. While the results are promising, future efforts should focus on age-matched datasets to further decouple aging from neurodegeneration. Additionally, automating sleep stage classification and improving robustness to signal artifacts (e.g., muscle movement) are necessary steps toward deploying these diagnostic tools in real-world clinical settings.

Summary updated

Abstract

Alzheimer's disease (AD) and sleep disorders exhibit a close association, where disruptions in sleep patterns often precede the onset of Mild Cognitive Impairment (MCI) and early-stage AD. This study delves into the potential of utilizing sleep-related electroencephalography (EEG) signals acquired through polysomnography (PSG) for the early detection of AD. Our primary focus is on exploring semi-supervised Deep Learning techniques for the classification of EEG signals due to the clinical scenario characterized by the limited data availability. The methodology entails testing and comparing the performance of semi-supervised SMATE and TapNet models, benchmarked against the supervised XCM model, and unsupervised Hidden Markov Models (HMMs). The study highlights the significance of spatial and temporal analysis capabilities, conducting independent analyses of each sleep stage. Results demonstrate the effectiveness of SMATE in leveraging limited labeled data, achieving stable metrics across all sleep stages, and reaching 90% accuracy in its supervised form. Comparative analyses reveal SMATE's superior performance over TapNet and HMM, while XCM excels in supervised scenarios with an accuracy range of 92 - 94%. These findings underscore the potential of semi-supervised models in early AD detection, particularly in overcoming the challenges associated with the scarcity of labeled data. Ablation tests affirm the critical role of spatio-temporal feature extraction in semi-supervised predictive performance, and t-SNE visualizations validate the model's proficiency in distinguishing AD patterns. Overall, this research contributes to the advancement of AD detection through innovative Deep Learning approaches, highlighting the crucial role of semi-supervised learning in addressing data limitations.
BibTeX
@misc{gallegovinaras2024alzheimer,
  author = {Lorena Gallego-Viñarás and Juan Miguel Mira-Tomas and Anna Michela-Gaeta and Gerard Pinol-Ripoll and Ferrán Barbé and Pablo M. Olmos and Arrate Muñoz-Barrutia},
  title = {{Alzheimer's disease detection in PSG signals}},
  year = {2024},
  eprint = {2404.03549},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2404.03549},
}
Figure